MedTrace Logo

Changes in FeNO Value During Pulmonary Rehabilitation in Patients with Asthma

NCT06751550 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2025-01-08

No results posted yet for this study

Summary

This study investigates the use of fractional exhaled nitric oxide (FeNO) measurement to monitor non-pharmacological therapy during a three-week inpatient rehabilitation programme for asthma patients. It compares FeNO levels (measured three times a day) with clinical parameters and quality of life to analyse daily fluctuations and the acute effect of exercise training on FeNO levels. As FeNO is a non-invasive biomarker of airway inflammation, this study aims to expand its role in therapy monitoring and explore its application in a rehabilitation setting.

Conditions

  • Asthma Bronchiale
  • Asthmatic Patients
  • Asthmatics

Sponsors & Collaborators

  • Bosch Healthcare Solutions GmbH

    collaborator INDUSTRY

  • Schön Klinik Berchtesgadener Land

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-17
Primary Completion
2024-12-20
Completion
2024-12-20

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06751550 on ClinicalTrials.gov